Adherence to Topical Hydrocortisone 17-butyrate 0.1% (Locoid®) Using Different Vehicles in Adults With Atopic Dermatitis

• Status: Completed
• Trial end date: 2008-09-01

Summary

The purpose of this research study is to better understand adherence to Locoid when people use it to treat atopic dermatitis.

• Phase: Phase 4

Details

• Lead Sponsor: Wake Forest University
• Treatments: Butyric Acid; Cortisol succinate; Hydrocortisone; Hydrocortisone 17-butyrate 21-propionate; Hydrocortisone acetate; Hydrocortisone hemisuccinate; Hydrocortisone-17-butyrate